Idexx Laboratories (NASDAQ:IDXX) reported Q1 2018 earnings this Morning, coming in at $1.01 per share, beating Wall Street’s estimates of $0.92 per Share. Revenue for the quarter came in at $537.60 million beating analyst estimates of $525.14 million Recent Insider Trading for Idexx Laboratories (NASDAQ:IDXX)
- On 2/28/2018 Daniel M Junius, Director, sold 2,974 with an average share price of $190.06 per share and the total transaction amounting to $565,238.44.
- On 2/22/2018 William T End, Director, sold 4,000 with an average share price of $184.48 per share and the total transaction amounting to $737,920.00.
- On 2/14/2018 Lawrence D Kingsley, Director, bought 1,000 with an average share price of $178.05 per share and the total transaction amounting to $178,050.00.
- On 2/8/2018 Jonathan W Ayers, Chairman, sold 22,000 with an average share price of $177.52 per share and the total transaction amounting to $3,905,440.00.
- On 2/7/2018 Bruce L Claflin, Director, bought 1,000 with an average share price of $179.58 per share and the total transaction amounting to $179,580.00.
- On 2/6/2018 Jonathan W Ayers, Chairman, sold 36,000 with an average share price of $179.28 per share and the total transaction amounting to $6,454,080.00.
Dividend History for Idexx Laboratories (NASDAQ:IDXX)
Recent Trading for Idexx Laboratories (NASDAQ:IDXX) Shares of Idexx Laboratories closed the previous trading session at 199.77 up +3.99 2.04% with shares trading hands.